Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.94)
# 617
Out of 5,104 analysts
485
Total ratings
43.78%
Success rate
12.89%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GLSI Greenwich LifeSciences | Maintains: Buy | $39 → $50 | $19.47 | +156.81% | 9 | Dec 30, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $23.89 | +33.95% | 5 | Dec 29, 2025 | |
| LEXX Lexaria Bioscience | Maintains: Buy | $4 → $1.5 | $0.65 | +129.36% | 8 | Dec 26, 2025 | |
| BEAT HeartBeam | Maintains: Buy | $2.5 → $5.5 | $2.43 | +126.34% | 2 | Dec 10, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $19 → $21 | $11.82 | +77.66% | 30 | Dec 8, 2025 | |
| AXGN Axogen | Maintains: Buy | $26 → $39 | $31.00 | +25.81% | 3 | Dec 5, 2025 | |
| BLTE Belite Bio | Maintains: Buy | $98 → $185 | $159.27 | +16.15% | 22 | Dec 1, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.59 | +340.25% | 3 | Nov 24, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $4.83 | +86.34% | 21 | Nov 24, 2025 | |
| CODX Co-Diagnostics | Reiterates: Neutral | n/a | $5.56 | - | 24 | Nov 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $13 → $9 | $3.49 | +157.88% | 11 | Nov 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2.5 → $1.5 | $0.27 | +449.45% | 4 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.53 | +176.68% | 1 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.74 | +444.22% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $36 | $22.99 | +56.59% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $8.00 | -12.50% | 5 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $49.91 | +38.25% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $19.98 | +110.23% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $62.36 | +42.72% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.50 | +233.33% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $16.58 | +2.53% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.63 | +296.83% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $13.57 | +150.55% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.62 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.23 | +213.90% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.16 | +121.52% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.31 | +132.02% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.02 | +395.05% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.27 | +214.96% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.62 | +455.56% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $4.10 | +95.12% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $17.48 | +31.58% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $12.68 | +26.18% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $15.17 | +18.66% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $19.14 | +30.62% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.27 | +136.22% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.38 | +681.25% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.27 | +1,221.59% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.16 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $1.79 | +27,832.96% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $0.36 | +30,236.46% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $11.27 | +325.91% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $100.55 | -81.10% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.84 | - | 2 | Apr 16, 2020 |
Greenwich LifeSciences
Dec 30, 2025
Maintains: Buy
Price Target: $39 → $50
Current: $19.47
Upside: +156.81%
BioLife Solutions
Dec 29, 2025
Reiterates: Buy
Price Target: $32
Current: $23.89
Upside: +33.95%
Lexaria Bioscience
Dec 26, 2025
Maintains: Buy
Price Target: $4 → $1.5
Current: $0.65
Upside: +129.36%
HeartBeam
Dec 10, 2025
Maintains: Buy
Price Target: $2.5 → $5.5
Current: $2.43
Upside: +126.34%
Ocular Therapeutix
Dec 8, 2025
Maintains: Buy
Price Target: $19 → $21
Current: $11.82
Upside: +77.66%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $26 → $39
Current: $31.00
Upside: +25.81%
Belite Bio
Dec 1, 2025
Maintains: Buy
Price Target: $98 → $185
Current: $159.27
Upside: +16.15%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.59
Upside: +340.25%
Alpha Tau Medical
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $4.83
Upside: +86.34%
Co-Diagnostics
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $5.56
Upside: -
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.49
Upside: +157.88%
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.27
Upside: +449.45%
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $2.53
Upside: +176.68%
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.74
Upside: +444.22%
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $22.99
Upside: +56.59%
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $8.00
Upside: -12.50%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $49.91
Upside: +38.25%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $19.98
Upside: +110.23%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $62.36
Upside: +42.72%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.50
Upside: +233.33%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $16.58
Upside: +2.53%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.63
Upside: +296.83%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $13.57
Upside: +150.55%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.62
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.23
Upside: +213.90%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $3.16
Upside: +121.52%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.31
Upside: +132.02%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.02
Upside: +395.05%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.27
Upside: +214.96%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $1.62
Upside: +455.56%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $4.10
Upside: +95.12%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $17.48
Upside: +31.58%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $12.68
Upside: +26.18%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $15.17
Upside: +18.66%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $19.14
Upside: +30.62%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.27
Upside: +136.22%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.38
Upside: +681.25%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.27
Upside: +1,221.59%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.16
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $1.79
Upside: +27,832.96%
Feb 21, 2024
Reiterates: Buy
Price Target: $110
Current: $0.36
Upside: +30,236.46%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $11.27
Upside: +325.91%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $100.55
Upside: -81.10%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.84
Upside: -